Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients
Olusayo Louise- Oluwasanmi *
Department of Genetics and Human Genetics, Howard University, 4th and College Streets, NW. Washington, D.C. 20059, USA.
*Author to whom correspondence should be addressed.
Abstract
The symptoms of COVID-19, leading to pulmonary edema and the need for ventilators may be due to the fact that the virus increases bradykinin levels. If true, administering bradykinin blockers can provide a cheap way to reduce the severity of the symptoms and the burden on hospital resources, and, ultimately, the fatality rate.
Keywords: ACEIs, positive feedback, pulmonary edema.